The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Indivior Pharmaceuticals's Dividend Payout Ratio for the
months ended in Mar. 2026 was 0.00.
The historical rank and industry rank for Indivior Pharmaceuticals's Dividend Payout Ratio or its related term are showing as below:
During the past 13 years, the highest Dividend Payout Ratio of Indivior Pharmaceuticals was 0.28. The lowest was 0.28. And the median was 0.28.
FRA:E7P's Dividend Payout Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.37 * Ranked among companies with meaningful Dividend Payout Ratio only.
During the past 13 years, the highest Trailing Annual Dividend Yield of Indivior Pharmaceuticals was 3.92%. The lowest was 0.00%. And the median was 2.45%.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Indivior Pharmaceuticals (FRA:E7P) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Indivior Pharmaceuticals Dividend Payout Ratio Related Terms
Indivior Pharmaceuticals Dividend Payout Ratio Historical Data
* Premium members only.
The historical data trend for Indivior Pharmaceuticals's Dividend Payout Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Indivior Pharmaceuticals Dividend Payout Ratio Chart
FRA:E7P vs AMRX, KNSA, LQDA: Dividend Payout Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Indivior Pharmaceuticals's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Indivior Pharmaceuticals Dividend Payout Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Indivior Pharmaceuticals's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where Indivior Pharmaceuticals's Dividend Payout Ratio falls into.
Indivior Pharmaceuticals Dividend Payout Ratio Calculation
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
Indivior Pharmaceuticals's Dividend Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Indivior Pharmaceuticals (FRA:E7P) has a Dividend Payout Ratio of 0.00 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Indivior Pharmaceuticals and its competitors. Over the past decade, Indivior Pharmaceuticals' Dividend Payout Ratio has ranged from 0.28 to 0.28. According to the industry distribution chart, Indivior Pharmaceuticals ranks #999999 out of 443 companies in the Drug Manufacturers industry.
Is Indivior Pharmaceuticals' Dividend Payout Ratio too high?
Indivior Pharmaceuticals' current Dividend Payout Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 0.28 to a high of 0.28. Based on the distribution chart, Indivior Pharmaceuticals ranks #999999 out of 443 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Indivior Pharmaceuticals has a GF Score™ of 56/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Indivior Pharmaceuticals' Dividend Payout Ratio compare to AMRX and KNSA?
According to the Drug Manufacturers industry distribution chart, Indivior Pharmaceuticals ranks #999999 out of 443 companies for Dividend Payout Ratio. This places Indivior Pharmaceuticals in the lower half of its industry. The industry median Dividend Payout Ratio is 0.37. Historically, Indivior Pharmaceuticals' own Dividend Payout Ratio has ranged from 0.28 to 0.28 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Drug Manufacturers company?
The median Dividend Payout Ratio among Drug Manufacturers companies is 0.37, based on 443 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Indivior Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Dividend Payout Ratio is 0.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Indivior Pharmaceuticals's current Dividend Payout Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indivior Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Indivior Pharmaceuticals (FRA:E7P) is currently considered Significantly Overvalued. The stock's GF Value™ is €19.18, compared to a current price of €34.60 — trading 80.4% above its estimated fair value. The current Dividend Payout Ratio is 0.00. Indivior Pharmaceuticals' overall GF Score™ is 56/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Indivior Pharmaceuticals (FRA:E7P), the current Dividend Payout Ratio is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Indivior Pharmaceuticals (FRA:E7P) Overvalued in 2026?
Based on GuruFocus' analysis, Indivior Pharmaceuticals stock appears to be overvalued.
The current stock price of €34.60 is trading 80.4% above its estimated GF Value™ of €19.18.
GuruFocus considers Indivior Pharmaceuticals to be Significantly Overvalued.
Key valuation signals for FRA:E7P:
Dividend Payout Ratio: 0.00
GF Value™: €19.18 vs. price of €34.60 (80.4% above fair value)
No single metric tells the full story. See the FRA:E7P stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).
56GF Score
Get the complete analysis for FRA:E7P
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:E7P has been successfully added to your 
